Physician profile
Thomas C Lackey
NPI 1114955598
$50,876.70
in general payments reported to CMS, 2019-2025
39 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $21K · 2021: $10K · 2022: $3,715 · 2023: $3,439 · 2024: $417 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $892 · Gift: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $892.11 |
| Gift | $299.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $27,452.83 | 2020-2024 | Davinci Xi, Da Vinci Surgical System |
| Medtronic Vascular, INC. | $15,483.02 | 2019-2020 | |
| Boston Scientific Corporation | $3,249.25 | 2021-2025 | Varithena Administration Pack |
| Medtronic, INC. | $2,698.85 | 2021-2023 | Ligasure |
| Smith+Nephew, INC. | $197.52 | 2020-2025 | Stravix, Grafix Pl, Collagenase Santyl |
| Organogenesis INC. | $189.88 | 2020-2023 | Puraply |
| Kerecis Limited | $153.64 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ethicon US, LLC | $147.42 | 2019-2022 | |
| Tela Bio, INC. | $136.35 | 2020-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Tactile Systems Technology INC | $118.28 | 2025 | Flexitouch Plus, Nimbl |
| Kci USA, INC. | $115.85 | 2021-2023 | Activ.A.C., 3m Coban, Kerramax Care |
| Venclose INC. | $90.00 | 2020 | |
| Convatec INC. | $76.88 | 2023-2024 | |
| Angiodynamics, INC. | $63.23 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $56.79 | 2019-2020 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.